These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8019431)

  • 41. High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
    Matsuda Y
    Kobe J Med Sci; 1993 Feb; 39(1):1-14. PubMed ID: 8366661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
    Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A spin label study of the effect of chrysotile asbestos on erythrocyte membranes.
    Gendek E; Bartosz G; Leyko W
    Br J Ind Med; 1984 Feb; 41(1):46-50. PubMed ID: 6318801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A comparative study of the lipid phase in native and circulating multiple-modified low-density lipoproteins of human blood by the use of the spin probe method].
    Vakhrusheva TV; Panasenko OM; Mel'nichenko AA; Orekhov AN
    Biofizika; 2005; 50(4):652-9. PubMed ID: 16212056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural alterations of erythrocyte membrane components induced by exhaustive exercise.
    Brzeszczynska J; Pieniazek A; Gwozdzinski L; Gwozdzinski K; Jegier A
    Appl Physiol Nutr Metab; 2008 Dec; 33(6):1223-31. PubMed ID: 19088781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Propranolol-induced structural changes in human erythrocyte ghost membranes. A spin label study.
    Surewicz WK
    Biochem Pharmacol; 1982 Mar; 31(5):691-4. PubMed ID: 6282275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of iron ion-induced oxidative damage of erythrocyte membranes and low density lipoprotein by a Maillard product, 4-hydroxy-2(or 5)-ethyl-5(or 2)-methyl-3(2H)-furanone (HEMF).
    Ando K; Ogawa K; Li X; Kikugawa K
    Biol Pharm Bull; 2000 Jun; 23(6):689-94. PubMed ID: 10864016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of plasma lipoproteins with erythrocytes. II. Modulation of membrane-associated enzymes.
    Hui DY; Harmony JA
    Biochim Biophys Acta; 1979 Feb; 550(3):425-34. PubMed ID: 217430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-enzymatic glycosylation and the chronic complications of diabetes: an overview.
    Kennedy L; Baynes JW
    Diabetologia; 1984 Feb; 26(2):93-8. PubMed ID: 6370764
    [No Abstract]   [Full Text] [Related]  

  • 50. Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus.
    Maulucci G; Cordelli E; Rizzi A; De Leva F; Papi M; Ciasca G; Samengo D; Pani G; Pitocco D; Soda P; Ghirlanda G; Iannello G; De Spirito M
    PLoS One; 2017; 12(9):e0184109. PubMed ID: 28880900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Menadione-induced cytotoxicity effects on human erythrocyte membranes studied by electron paramagnetic resonance.
    Trad CH; Butterfield DA
    Toxicol Lett; 1994 Aug; 73(2):145-55. PubMed ID: 8048083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human red blood cell membrane potential and fluidity in glucose solutions.
    Zavodnik IB; Piasecka A; Szosland K; Bryszewska M
    Scand J Clin Lab Invest; 1997 Feb; 57(1):59-63. PubMed ID: 9127458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine.
    Waczulíkova I; Sikurová L; Cársky J; Strbová L; Krahulec B
    Gen Physiol Biophys; 2000 Dec; 19(4):381-92. PubMed ID: 11409841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of imidazoacridinones, new antineoplastic agents, on the human erythrocyte membrane.
    Jóźwiak Z; Pacholska M; Szwarocka A
    Biochem Mol Biol Int; 1997 Nov; 43(4):883-90. PubMed ID: 9385448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of oxidized LDL on hemolytic resistance of erythrocyte.
    Azizova OA; Piryazev AP; Nikitina NA; Savchenkova AP; Lopukhin YM
    Bull Exp Biol Med; 2002 Aug; 134(2):137-8. PubMed ID: 12459834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of insulin on human erythrocyte membrane fluidity in diabetes mellitus.
    Bryszewska M; Leyko W
    Diabetologia; 1983 May; 24(5):311-3. PubMed ID: 6347778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between the glycation of erythrocyte membrane proteins and membrane fluidity.
    Bryszewska M; Szosland K
    Clin Biochem; 1988 Jan; 21(1):49-51. PubMed ID: 3345599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for a relationship between protein glycation and red blood cell membrane fluidity.
    Birlouez-Aragon I; Scalbert-Menanteau P; Morawiec M; Shafiezadeh M
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1107-13. PubMed ID: 2390079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibility to in vitro lipid peroxidation of low density lipoproteins and erythrocyte membranes from liver cirrhotic patients.
    Taus M; Ferretti G; Dousset N; Moreau J; Battino M; Solera ML; Valdiguié P; Curatola G
    Scand J Clin Lab Invest; 1994 Apr; 54(2):147-53. PubMed ID: 8197401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Do E-series prostaglandins and their metabolites influence oxidation of native and glycated low-density lipoproteins?
    Sobal G; Menzel JE; Sinzinger H
    Prostaglandins Other Lipid Mediat; 1998 Jan; 55(1):67-76. PubMed ID: 9661219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.